Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
34.7M
-
Shares change
-
+2.61M
-
Total reported value, excl. options
-
$220M
-
Value change
-
+$16.5M
-
Put/Call ratio
-
0
-
Number of buys
-
25
-
Number of sells
-
-2
-
Price
-
$6.34
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q2 2024
110 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q2 2024.
Pulmonx Corp - COMMON STOCK (LUNG) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.7M shares
of 40.4M outstanding shares and own 86.06% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.71M shares), FMR LLC (5.28M shares), MORGAN STANLEY (3.47M shares), BlackRock Inc. (2.67M shares), VANGUARD GROUP INC (2.18M shares), DEUTSCHE BANK AG\ (1.29M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.06M shares), JPMORGAN CHASE & CO (1.03M shares), GEODE CAPITAL MANAGEMENT, LLC (882K shares), and VICTORY CAPITAL MANAGEMENT INC (834K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.